DOI:
10.1055/s-00000041
Neuropediatrics
LinksClose Window
References
Brodie MJ, Czapinski P, Pazdera L. et al; GWEP1330 Study Group.
A phase 2 randomized controlled trial of the efficacy and safety of Cannabidivarin as add-on therapy in participants with inadequately controlled focal seizures.
Cannabis Cannabinoid Res 2021;
6 (06) 528-536
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.